“rna” Archives

in
Entry Author Date Location
Sarepta Inks Codiak Deal to Explore Combining Exosomes, Muscle Meds 06/22/20 Boston
Accent, AstraZeneca Ink Cancer Drug Deal to Block RNA-Modifying Proteins 06/04/20 Boston
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics 04/08/20 Boston
Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers 04/08/20 National
Dynacure Adds $55M As RNA-Targeted Muscle Disorder Drug Enters Clinic 04/03/20 Boston
With $80M, ReCode Looks to Advance RNA Therapies for Lung Diseases 03/26/20 San Francisco
Qiagen Juices RNA Extraction Kit Capacity to Feed Coronavirus Test Needs 03/17/20 National
UC San Diego Health Develops COVID-19 Test, Begins Testing Patients 03/14/20 San Diego
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Roche Trial of Ionis Huntington’s Disease Drug Halted After Side Effects 03/05/20 San Diego
Vizgen Launches With $14M to Market New Subcellular Imaging Technique 01/30/20 Boston
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs 01/09/20 San Diego
Avidity Bio Adds $100M to Advance R&D of Muscle Disorder Drugs 11/13/19 San Diego
Ionis Gets $25M From GSK for Experimental Hepatitis B Program 08/27/19 San Diego
San Antonio to Honor Regenerative Medicine Pioneer Stephen Badylak 07/17/19 Texas
Skyhawk Inks Deal With Genentech for Cancer and Neuro Drug Discovery 07/16/19 Boston
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits 06/26/19 San Francisco
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More 05/24/19 National
Biogen, Taking Its Crisis “Seriously,” Keeps Focus on Neuroscience 04/24/19 Boston
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help 04/18/19 Boston
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More 11/16/18 National
Ribometrix Takes Aim at “Undruggable” RNA with $30M Series A Funding 11/13/18 Raleigh Durham
With $90M Round, Stoke Eyes a “Spinraza For Epilepsy” And a 2019 IPO 10/23/18 Boston
In New York, Gotham Starts Up With $54M for RNA-Modifying Drugs 10/10/18 New York
Catch CRISPR 2.0, RNA-Targeting Drugs & More At “Disruptors” on Oct. 17 09/26/18 Boston
Lasker Awards Recognize Propofol Discovery, Women in Science Advocate & Others 09/11/18 National
Skyhawk Lands $100M from Funding & Celgene Pact for RNA-Targeted Drugs 06/26/18 Boston
Accent Therapeutics Debuts With $40M To Target RNA Modification 05/18/18 Boston
Page 1 of 3 next page »